These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
563 related articles for article (PubMed ID: 28577310)
1. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis. Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310 [TBL] [Abstract][Full Text] [Related]
2. Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome. Schneider NB; Pastor T; Paula AE; Achatz MI; Santos ÂRD; Vianna FSL; Rosset C; Pinheiro M; Ashton-Prolla P; Moreira MÂM; Palmero EI; Cancer Med; 2018 May; 7(5):2078-2088. PubMed ID: 29575718 [TBL] [Abstract][Full Text] [Related]
3. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Haraldsdottir S; Hampel H; Tomsic J; Frankel WL; Pearlman R; de la Chapelle A; Pritchard CC Gastroenterology; 2014 Dec; 147(6):1308-1316.e1. PubMed ID: 25194673 [TBL] [Abstract][Full Text] [Related]
4. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome. Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ; Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173 [TBL] [Abstract][Full Text] [Related]
5. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers. Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875 [TBL] [Abstract][Full Text] [Related]
6. Implication of DNA repair genes in Lynch-like syndrome. Xicola RM; Clark JR; Carroll T; Alvikas J; Marwaha P; Regan MR; Lopez-Giraldez F; Choi J; Emmadi R; Alagiozian-Angelova V; Kupfer SS; Ellis NA; Llor X Fam Cancer; 2019 Jul; 18(3):331-342. PubMed ID: 30989425 [TBL] [Abstract][Full Text] [Related]
7. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668 [TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of hereditary nonpolyposis colorectal cancer: the contribution of allele-specific expression and other assays to diagnostic algorithms. De Lellis L; Aceto GM; Curia MC; Catalano T; Mammarella S; Veschi S; Fantini F; Battista P; Stigliano V; Messerini L; Mareni C; Sala P; Bertario L; Radice P; Cama A PLoS One; 2013; 8(11):e81194. PubMed ID: 24278394 [TBL] [Abstract][Full Text] [Related]
9. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report. Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350 [TBL] [Abstract][Full Text] [Related]
11. Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6. Morak M; Käsbauer S; Kerscher M; Laner A; Nissen AM; Benet-Pagès A; Schackert HK; Keller G; Massdorf T; Holinski-Feder E Fam Cancer; 2017 Oct; 16(4):491-500. PubMed ID: 28528517 [TBL] [Abstract][Full Text] [Related]
12. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Niessen RC; Hofstra RM; Westers H; Ligtenberg MJ; Kooi K; Jager PO; de Groote ML; Dijkhuizen T; Olderode-Berends MJ; Hollema H; Kleibeuker JH; Sijmons RH Genes Chromosomes Cancer; 2009 Aug; 48(8):737-44. PubMed ID: 19455606 [TBL] [Abstract][Full Text] [Related]
13. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients. Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297 [TBL] [Abstract][Full Text] [Related]
14. Toward a better definition of EPCAM deletions in Lynch Syndrome: Report of new variants in Italy and the associated molecular phenotype. Cini G; Quaia M; Canzonieri V; Fornasarig M; Maestro R; Morabito A; D'Elia AV; Urso ED; Mammi I; Viel A Mol Genet Genomic Med; 2019 May; 7(5):e587. PubMed ID: 30916491 [TBL] [Abstract][Full Text] [Related]
15. EPCAM germline and somatic rearrangements in Lynch syndrome: identification of a novel 3'EPCAM deletion. Spaepen M; Neven E; Sagaert X; De Hertogh G; Beert E; Wimmer K; Matthijs G; Legius E; Brems H Genes Chromosomes Cancer; 2013 Sep; 52(9):845-54. PubMed ID: 23801599 [TBL] [Abstract][Full Text] [Related]
16. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins. Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416 [TBL] [Abstract][Full Text] [Related]
17. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing]. Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589 [No Abstract] [Full Text] [Related]
18. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study. Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783 [TBL] [Abstract][Full Text] [Related]
19. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome. Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989 [TBL] [Abstract][Full Text] [Related]
20. Integrating Tumor Sequencing Into Clinical Practice for Patients With Mismatch Repair-Deficient Lynch Syndrome Spectrum Cancers. Dixon K; Asrat MJ; Bedard AC; Binnington K; Compton K; Cremin C; Heidary N; Lohn Z; Lovick N; McCullum M; Mindlin A; O'Loughlin M; Petersen T; Portigal-Todd C; Scott J; St-Martin G; Thompson J; Turnbull R; Mung SW; Hong Q; Bezeau M; Bosdet I; Tucker T; Young S; Yip S; Aubertin G; Blood KA; Nuk J; Sun S; Schrader KA Clin Transl Gastroenterol; 2021 Aug; 12(8):e00397. PubMed ID: 34397043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]